A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma
出版年份 2018 全文链接
标题
A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma
作者
关键词
-
出版物
Liver Cancer
Volume 7, Issue 2, Pages 165-178
出版商
S. Karger AG
发表日期
2018-03-16
DOI
10.1159/000486460
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib
- (2017) Tim Meyer et al. LIVER INTERNATIONAL
- Systemic therapy in HCC: Lessons from brivanib
- (2014) David Bolos et al. JOURNAL OF HEPATOLOGY
- Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
- (2014) Martin Reck et al. LANCET ONCOLOGY
- Systemic therapies in hepatocellular carcinoma: present and future
- (2013) Gaetano Bertino et al. Future Oncology
- Fibroblast growth factor signaling in liver carcinogenesis
- (2013) Dalbir S. Sandhu et al. HEPATOLOGY
- The antiangiogenic ceiling in hepatocellular carcinoma: does it exist and has it been reached?
- (2013) Ghassan K Abou-Alfa et al. LANCET ONCOLOGY
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- (2012) Hashem B. El-Serag GASTROENTEROLOGY
- Impact of intra-individual molecular heterogeneity in personalized treatment of hepatocellular carcinoma
- (2012) Augusto Villanueva et al. HEPATOLOGY
- Targeted therapy of hepatocellular carcinoma: Present and future
- (2012) Stephen L Chan et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer
- (2011) Jonathan A. Ledermann et al. JOURNAL OF CLINICAL ONCOLOGY
- HCC and angiogenesis: possible targets and future directions
- (2011) Andrew X. Zhu et al. Nature Reviews Clinical Oncology
- Pharmacokinetics and metabolism of BIBF 1120 after oral dosing to healthy male volunteers
- (2011) Peter Stopfer et al. XENOBIOTICA
- Eastern asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma
- (2010) Winnie Yeo et al. BMC CANCER
- Antitumor Activity of BIBF 1120, a Triple Angiokinase Inhibitor, and Use of VEGFR2+pTyr+ Peripheral Blood Leukocytes as a Pharmacodynamic Biomarker In Vivo
- (2010) Kanae Kudo et al. CLINICAL CANCER RESEARCH
- Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts' opinion
- (2010) Pei-Jer Chen et al. LIVER INTERNATIONAL
- The role of signaling pathways in the development and treatment of hepatocellular carcinoma
- (2010) S Whittaker et al. ONCOGENE
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Hepatocellular carcinoma in the Asia pacific region
- (2009) Man-Fung Yuen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
- (2008) F. Hilberg et al. CANCER RESEARCH
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now